Evidence map›Paper›PMID 28967091›Full record

ArticleTumori2017

Trends in lung cancer and smoking behavior in Italy: an alarm bell for women.

Annalisa Trama, Roberto Boffi, Paolo Contiero, Carlotta Buzzoni, Roberta Pacifici, Lucia Mangone, AIRTUM Working Group

Open access · hybridAbstract read
In one paragraph

Article in Tumori, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 20 institutions in 4 countries.

Annalisa TramaEvaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan - Italy.
Roberto BoffiTobacco Control Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan - Italy.
Paolo ContieroEnvironmental Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan - Italy.
Carlotta BuzzoniCancer Prevention and Research Institute, Istituto per lo Studio e la Prevenzione Oncologica, Florence - Italy.
Roberta PacificiOsservatorio Fumo Alcol e Droga, Istituto Superiore di Sanità, Rome - Italy.
Lucia MangoneInterinstitutional Epidemiology Unit, AUSL Reggio Emilia, Reggio Emilia - Italy.
AIRTUM Working Group
Azienda Sanitaria Unità Locale di Reggio Emilia · ITIstituto per lo Studio e la Prevenzione Oncologica · ITFondazione IRCCS Istituto Nazionale dei Tumori · ITPiedmont Reference Center for Epidemiology and Cancer Prevention · ITUniversity of Perugia · ITRegione Campania · ITRegione del Veneto · ITAzienda Ospedaliero-Universitaria di Modena · ITAzienda Sanitaria Locale Viterbo · ITAzienda Unità Sanitaria Locale di Ferrara · ITIstituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori · ITTelio (Norway) · NOAzienda Unita' Sanitaria Locale Di Modena · ITAdvanced Research Projects Agency - Energy · USAgenzia Regionale Sanitaria della Puglia · ITOspedale Vito Fazzi · ITUniversità di Camerino · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITOspedale di Bolzano · ITRegione Lombardia

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe epidemiology of lung cancer is changing worldwide, with smoking being the key driver of lung cancer incidence and mortality. Our aim is to analyze the incidence, survival and mortality trends in Italy in the framework of the 2017 survey on smoking behavior in Italy.

methodsAIRTUM 2017 reports on cancer survival and incidence; 2017 survey on smoking behavior in Italy.

resultsMen achieved progress in lung cancer control characterized by a decrease in incidence and mortality and an increase in survival. The decreasing use of tobacco in men (from 60% in the 1960s to 24% in 2017) was most likely responsible for the decreasing incidence and mortality. Women showed no progress: although survival improved slightly, the incidence and mortality were both on the rise. This was most likely due to the increasing smoking rates in women in the 1970s and 80s. Of major concern is the accelerated rise in the number of smoking women from 4.6 million in 2016 to 5.7 million in 2017 compared to the decrease observed in men (from 6.9 to 6 million).

conclusionsThe incidence and mortality trends in males clearly demonstrate that primary prevention is the most effective way to reduce lung cancer mortality. By contrast, a 24% increase in the prevalence of smoking among women in just 1 year is extremely worrying for the future, and calls for immediate action by targeted strategies to reduce tobacco consumption in women and avert the dreadful prospect of a lung cancer epidemic in Italy.

Indexed as

Age DistributionFemaleForecastingHumansIncidenceItalyLung NeoplasmsMalePrevalenceSmoking

Identifiers

PMID28967091
PMCPMC6379803
OpenAlexW2760089207

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.